Sunday, 22 November 2026
Rīga TV

World and Latvian news in one place

TechnologyPublished: 22 November 2026 at 15:04

GLP-1 drugs may link obesity treatment to wider food system and environmental change

Two UK researchers who study how GLP-1 drugs may change food demand say the medicines should not replace reform of the food environment. They call for health, agriculture and environmental protection to be tackled together.

Foto: Ars Technica

Roslyn Henry, a lecturer at the University of Aberdeen's School of Biological Sciences, and Peter Alexander, Professor of Global Food Systems at the University of Edinburgh, have published a commentary on GLP-1 drugs, which are used to treat obesity. The authors examine how changes in food demand linked to these medicines could spread across the food system, including agriculture, land use and the environment. The piece first appeared on The Conversation and was republished by Ars Technica.

More than a personal choice

The authors note that obesity has often been framed as a "lifestyle disease", with individuals blamed for lacking willpower. In their view, diets are shaped by what food is available, what it costs, how it is marketed, where shops are located and what is most convenient. In many high-income countries it is very easy to consume large amounts of cheap, energy-dense food. The UK government-commissioned national food strategy, finalised in 2021, made the same point: better diets cannot depend only on asking individuals to choose better, and the wider food environment must change.

The researchers stress that their findings should not be read as meaning that people living with obesity have a duty to lose weight to reduce the environmental impact of food production.

Medicine alongside food system change

A healthier diet, they argue, is not simply one with fewer calories. It could mean more fruit, vegetables and other nutritious foods, with less excessive consumption of foods linked to poor health. Such shifts affect human health as well as agriculture, land use and the environment.

The authors say GLP-1 medicines can help people eat less in an unhealthy food environment, but should not become a technological fix that lets the food system avoid scrutiny. The long-term goal, they write, should be to make a healthier, more sustainable diet easier and more affordable.

Comments

0/1500

Comments are automatically moderated. No hate, threats, personal data or spam.

Loading comments…

More in this category